$6.21 0.32 (+5.43%)
11/6/2009 4:00 PM

Allos Therapeutics, Inc. (ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Current Price $6.21 Mkt Cap $645.47M
Open $0.00 P/E Ratio 0.00
Prev. Close $5.89 Div. (Yield) N/A (N/A)
Daily Range $6.05 - $6.29 Volume 2,930,976
52-Wk Range $4.68 - $9.30 Avg. Daily Vol. 3,733,000

ALTH News and Commentary

Caps

How do you think ALTH will perform vs the S&P 500?

Add Stock to Watchlist

All Members

220 Outperform
14 Underperform
 

All-Star Members

65 Outperform
4 Underperform
 

Wall Street

13 Outperform
0 Underperform
 

Top ALTH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

codergrrl (< 20)
Submitted January 07, 2008

Allos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule therapeutics for the treatment of cancer.

0 Comments | Reply | Report this Post

Ruthie203 (24.30)
Submitted February 15, 2008

Wow, I just can't see it. With constant new management, directors, increased stock options, no viable product, living off investor money with promises that FDA might approve 2 bios, seems too risky for me. I might go it if not for the exit of 2… More

0 Comments | Reply | Report this Post
ALTH VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ALTH.

Recs

0
Member Avatar randomvariable (99.24) Submitted: 10/22/2009 12:34:27 PM : Outperform Start Price: $6.51 ALTH Score: -3.52

Recent FDA action, solid cash position, hopefully this will become profitable.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar spundun (68.07) Submitted: 10/6/2009 8:42:47 PM : Outperform Start Price: $7.18 ALTH Score: -15.28

portefeuille, all stars.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar pprimo (< 20) Submitted: 10/3/2009 10:24:30 PM : Outperform Start Price: $7.14 ALTH Score: -17.14

Because its got cancer treatments recently approved by the FDA that will hit the market in October. This will go from a development/research company to a revenue producing company. the potential for a partnership with a large drug company is high.

Report this Post 0 Comments | Reply | Permalink
View All 28 Pitches »

Leaderboard

Find the members with the highest scoring picks in ALTH.

Score Leader

AirForceFool

AirForceFool (99.95) Score: +99.36

These guys did so well for me, I finally bought some shares (only 100)... made a few bucks on them and closed out about 20% up. They certainly are volatile.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Gcefaloni < 20 9/18/2006 Outperform 3M $3.65 +70.14% -13.71% +83.85
mtsafe 98.84 10/25/2006 3/2/2008 Outperform 5Y $3.84 +61.72% -17.47% +79.19 1 Comment
Gharabally 83.24 10/26/2006 Outperform 3Y $3.87 +60.47% -18.02% +78.49
Evita100 < 20 10/2/2006 Outperform 1Y $3.80 +63.42% -14.83% +78.25
Rexkay < 20 10/9/2006 Outperform 3M $3.99 +55.64% -15.68% +71.32 1 Comment
HDbaloo 79.90 10/10/2006 Outperform NS $4.01 +54.86% -15.84% +70.70
da723955 < 20 7/17/2007 Outperform 1Y $4.50 +38.00% -27.17% +65.17
Gabers11 32.77 6/22/2007 Outperform 3Y $4.45 +39.55% -25.04% +64.59
hennyhughes < 20 10/20/2006 Outperform 3W $4.31 +44.08% -16.95% +61.03
Maraja 75.22 8/8/2007 Outperform 5Y $4.61 +34.71% -24.53% +59.24
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackLeerinkSwan 84.26 7/14/2009 Outperform NS $7.56 -17.86% +19.10% -36.96
TrackJimCramer < 20 2/27/2009 Outperform 3W $5.64 +10.11% +47.46% -37.35
TrackWachovia 35.10 12/4/2008 Outperform NS $6.01 +3.33% +27.72% -24.39
TrackCitigroup 21.22 6/26/2008 Outperform NS $6.49 -4.31% -15.34% +11.02
TrackMichaelBrus 93.35 2/14/2008 Outperform 1Y $6.75 -8.00% -17.40% +9.40
TrackBofASec 93.50 12/4/2007 Outperform NS $7.26 -14.46% -23.47% +9.01
TrackCollinsStew 68.32 11/8/2007 Outperform NS $5.90 +5.25% -23.95% +29.20
TrackSoros 65.62 9/30/2007 Outperform NS $4.75 +30.74% -26.44% +57.17 1 Comment
TrackRBCCapMkts 81.74 6/20/2007 Outperform NS $5.54 +12.09% -26.24% +38.33
TrackJimCramer < 20 2/13/2007 Underperform 3W $7.78 -27.51% -48.89% -21.39 2/28/2009 @ $5.64
TrackRodmanRen < 20 12/8/2006 Outperform NS $7.13 -12.89% -19.41% +6.52
TrackJMP < 20 12/7/2006 Outperform NS $7.15 -13.15% -20.02% +6.87
TrackUnterberg < 20 12/5/2006 Outperform NS $6.96 -8.19% -4.07% -4.12 6/24/2008 @ $6.39
TrackMDB < 20 10/11/2006 Outperform NS $3.92 +58.42% -15.67% +74.09
TrackNeedham < 20 9/5/2006 Outperform NS $4.16 +49.28% -13.16% +62.44

Featured Broker Partners